Redmile Group as of Sept. 30, 2021
Portfolio Holdings for Redmile Group
Redmile Group holds 75 positions in its portfolio as reported in the September 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fate Therapeutics (FATE) | 13.4 | $768M | 13M | 59.27 | |
Allakos (ALLK) | 3.9 | $226M | 2.1M | 105.87 | |
Igm Biosciences (IGMS) | 3.9 | $225M | 3.4M | 65.76 | |
Argenx Se Sponsored Adr (ARGX) | 3.8 | $221M | 731k | 302.00 | |
Adc Therapeutics Sa SHS (ADCT) | 3.6 | $205M | 7.5M | 27.16 | |
Amicus Therapeutics (FOLD) | 3.5 | $199M | 21M | 9.55 | |
The Beauty Health Company Com Cl A (SKIN) | 3.4 | $194M | 7.5M | 25.97 | |
Livanova SHS (LIVN) | 3.0 | $174M | 2.2M | 79.19 | |
Beam Therapeutics (BEAM) | 3.0 | $172M | 2.0M | 87.01 | |
Celldex Therapeutics Com New (CLDX) | 2.9 | $164M | 3.0M | 53.99 | |
Kymera Therapeutics (KYMR) | 2.9 | $164M | 2.8M | 58.74 | |
Invitae (NVTAQ) | 2.6 | $151M | 5.3M | 28.43 | |
Adagio Therapeutics (IVVD) | 2.4 | $137M | 3.2M | 42.24 | |
Deciphera Pharmaceuticals (DCPH) | 2.4 | $137M | 4.0M | 33.98 | |
Replimune Group (REPL) | 2.1 | $121M | 4.1M | 29.64 | |
Atara Biotherapeutics (ATRA) | 2.0 | $116M | 6.5M | 17.90 | |
Shattuck Labs (STTK) | 2.0 | $115M | 5.6M | 20.38 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.0 | $112M | 861k | 130.21 | |
Krystal Biotech (KRYS) | 1.8 | $104M | 2.0M | 52.21 | |
Seagen | 1.7 | $100M | 587k | 169.80 | |
Absci Corp (ABSI) | 1.6 | $93M | 8.0M | 11.63 | |
Nurix Therapeutics (NRIX) | 1.6 | $93M | 3.1M | 29.96 | |
Verve Therapeutics (VERV) | 1.5 | $88M | 1.9M | 47.00 | |
Scholar Rock Hldg Corp (SRRK) | 1.5 | $84M | 2.6M | 33.02 | |
Regenxbio Inc equity us cm (RGNX) | 1.5 | $84M | 2.0M | 41.92 | |
Oak Street Health | 1.4 | $80M | 1.9M | 42.53 | |
Repare Therapeutics Ord (RPTX) | 1.2 | $67M | 2.6M | 26.24 | |
Prothena Corp SHS (PRTA) | 1.1 | $64M | 902k | 71.23 | |
Alx Oncology Hldgs (ALXO) | 1.1 | $64M | 864k | 73.86 | |
Nevro (NVRO) | 1.1 | $63M | 543k | 116.38 | |
Annexon (ANNX) | 1.1 | $62M | 3.3M | 18.61 | |
Stoke Therapeutics (STOK) | 1.1 | $61M | 2.4M | 25.44 | |
Akero Therapeutics (AKRO) | 1.0 | $60M | 2.7M | 22.35 | |
Ngm Biopharmaceuticals (NGM) | 0.9 | $53M | 2.5M | 21.02 | |
Pliant Therapeutics (PLRX) | 0.9 | $52M | 3.1M | 16.88 | |
ICU Medical, Incorporated (ICUI) | 0.9 | $52M | 223k | 233.38 | |
Somalogic Class A Com | 0.9 | $49M | 4.0M | 12.39 | |
Genmab A/s Sponsored Ads (GMAB) | 0.9 | $49M | 1.1M | 43.70 | |
Anthem (ELV) | 0.8 | $48M | 128k | 372.80 | |
UnitedHealth (UNH) | 0.8 | $47M | 121k | 390.74 | |
ImmunoGen | 0.8 | $47M | 8.3M | 5.67 | |
Nuvation Bio Com Cl A (NUVB) | 0.8 | $45M | 4.5M | 9.94 | |
Epizyme | 0.7 | $38M | 7.5M | 5.12 | |
Medavail Holdings Ord | 0.6 | $34M | 12M | 2.92 | |
Tcr2 Therapeutics Inc cs | 0.6 | $33M | 3.8M | 8.51 | |
Gritstone Oncology Ord (GRTS) | 0.5 | $31M | 2.8M | 10.80 | |
Stevanato Group S P A Ord Shs (STVN) | 0.5 | $30M | 1.2M | 25.31 | |
Zymeworks | 0.4 | $26M | 882k | 29.04 | |
Neoleukin Therapeutics | 0.4 | $25M | 3.5M | 7.23 | |
Immatics SHS (IMTX) | 0.4 | $25M | 1.9M | 13.00 | |
Avita Therapeutics (RCEL) | 0.4 | $24M | 1.3M | 17.72 | |
Amedisys (AMED) | 0.4 | $22M | 150k | 149.10 | |
Bioventus Com Cl A (BVS) | 0.4 | $21M | 1.5M | 14.16 | |
Allovir (ALVR) | 0.4 | $21M | 837k | 25.06 | |
Dynamics Special Purpose Cor Class A Com | 0.3 | $19M | 1.9M | 9.94 | |
Alpha Teknova (TKNO) | 0.3 | $18M | 725k | 24.89 | |
Lifestance Health Group (LFST) | 0.3 | $18M | 1.2M | 14.50 | |
Lava Therapeutics Nv SHS (LVTX) | 0.3 | $17M | 2.8M | 5.92 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $16M | 2.1M | 7.79 | |
Zogenix Com New | 0.3 | $15M | 1.0M | 15.19 | |
1life Healthcare | 0.2 | $12M | 600k | 20.25 | |
Profound Med Corp Com New (PROF) | 0.2 | $12M | 787k | 14.64 | |
Hookipa Pharma Inc equity (HOOK) | 0.2 | $11M | 1.8M | 5.89 | |
Stereotaxis Com New (STXS) | 0.2 | $10M | 1.9M | 5.38 | |
Cytosorbents Corp Com New (CTSO) | 0.1 | $8.5M | 1.0M | 8.12 | |
Cabaletta Bio (CABA) | 0.1 | $8.5M | 696k | 12.16 | |
Itamar Med Sponsored Ads | 0.1 | $8.0M | 265k | 30.22 | |
Ayala Pharmaceuticals Incorporated | 0.1 | $7.6M | 668k | 11.34 | |
Atreca Cl A Com (BCEL) | 0.1 | $7.3M | 1.2M | 6.23 | |
Aprea Therapeutics | 0.1 | $3.6M | 695k | 5.11 | |
Xeris Pharmaceuticals | 0.1 | $3.3M | 1.4M | 2.45 | |
Yumanity Therapeutics | 0.0 | $614k | 60k | 10.32 | |
Tricida | 0.0 | $254k | 55k | 4.64 | |
Syros Pharmaceuticals | 0.0 | $174k | 39k | 4.47 | |
Ovid Therapeutics (OVID) | 0.0 | $137k | 41k | 3.37 |